2013 to 2022 Saw Rapid Increase in U.S. Pedestrian, Traffic Death Rates

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on March 25, 2025.

By Elana Gotkine HealthDay Reporter

TUESDAY, March 25, 2025 -- From 2013 to 2022, the U.S. pedestrian and road traffic death rate increased rapidly compared with a decrease in other high-income countries, according to research published in the March 13 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Rebecca B. Naumann, Ph.D., from the CDC in Atlanta, and colleagues examined changes in pedestrian and overall traffic death rates (deaths per 100,000 population) within an international context using 2013 to 2022 data from the United States and 27 other high-income countries, as well as early 2023 estimates from the United States.

The researchers found that overall U.S. pedestrian death rates increased 50 percent (from 1.55 to 2.33) compared with a median decrease of 24.7 percent in other countries. Furthermore, overall U.S. traffic death rates increased 22.5 percent during the study period (from 10.41 to 12.76) compared with a median decrease of 19.4 percent in the 27 other countries. The United States had the highest pedestrian death rates overall and among persons aged 15 to 24 and 25 to 64 years among all countries examined. Compared with rates in 2022, projected 2023 estimates suggested a potential decline in pedestrian and overall traffic deaths (2 and 4 percent, respectively).

"Whereas 2023 U.S. projections indicate a potential reduction in pedestrian deaths, increased and more widespread application of the Safe System approach could help accelerate and sustain progress," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2025-03-26 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords